GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mycotopia Therapies Inc (OTCPK:TPIA) » Definitions » Debt-to-Revenue

Mycotopia Therapies (Mycotopia Therapies) Debt-to-Revenue : N/A (As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Mycotopia Therapies Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Mycotopia Therapies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $1.27 Mil. Mycotopia Therapies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.00 Mil. Mycotopia Therapies's annualized Revenue for the quarter that ended in Mar. 2024 was $0.00 Mil.


Mycotopia Therapies Debt-to-Revenue Historical Data

The historical data trend for Mycotopia Therapies's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mycotopia Therapies Debt-to-Revenue Chart

Mycotopia Therapies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial N/A N/A N/A N/A N/A

Mycotopia Therapies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A N/A N/A N/A N/A

Competitive Comparison of Mycotopia Therapies's Debt-to-Revenue

For the Medical Care Facilities subindustry, Mycotopia Therapies's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mycotopia Therapies's Debt-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mycotopia Therapies's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Mycotopia Therapies's Debt-to-Revenue falls into.



Mycotopia Therapies Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Mycotopia Therapies's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1.091 + 0) / N/A
=N/A

Mycotopia Therapies's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.


Mycotopia Therapies Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Mycotopia Therapies's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Mycotopia Therapies (Mycotopia Therapies) Business Description

Traded in Other Exchanges
N/A
Address
18851 NE 29th Avenue, Suite 700, Aventura, FL, USA, 33180
Mycotopia Therapies Inc provides psychedelic therapies through technology-focused, data-driven, and medical-based solutions for people dealing with anxiety, depression, bipolar disorders, PTSD, ADHD, autism, and addictions.
Executives
Mark D. Williams director, 10 percent owner, officer: President, CEO & CFO 480 22ND STREET, BOX 2, HEYBURN ID 83336
Gibson Colin director, 10 percent owner, officer: Vice President 480 22ND STREET, BOX 2, HEYBURN ID 83336

Mycotopia Therapies (Mycotopia Therapies) Headlines

From GuruFocus

Ehave Issues Shareholder Letter and Provides Corporate Update

By GuruFocusNews GuruFocusNews 01-31-2022

Ehave Shareholder from CEO Ben Kaplan and Corporate Update

By Value_Insider Value_Insider 12-07-2022